Quarterly report pursuant to Section 13 or 15(d)

Revenue Disclosures - Changes in Contract Assets and Contract Liabilities (Details)

v3.23.3
Revenue Disclosures - Changes in Contract Assets and Contract Liabilities (Details)
6 Months Ended
Jun. 30, 2023
USD ($)
Deferred Revenue from company clinics  
Balance, beginning $ 7,471,549
Revenue recognized that was included in the contract liability at the beginning of the year (5,202,787)
six months ended June 30, 2023 5,420,686
Balance, ending 7,689,448
Deferred Revenue short and long-term  
Balance, beginning 16,629,735
Revenue recognized that was included in the contract liability at the beginning of the year (1,363,506)
Net increase during the period 1,447,506
Balance, ending 16,713,735
Deferred Franchise and Development Costs short and long-term  
Balance, beginning 6,761,738
Recognized as cost of revenue during the year (490,939)
Net increase during the period 393,665
Balance, ending $ 6,664,464